Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
August 10 2021 - 7:00AM
Business Wire
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling
customers to succeed through its offering of high-quality synthetic
DNA using its silicon platform, today announced that Jim Thorburn,
CFO of Twist Bioscience, and Patrick Finn, chief commercial
officer, will host a fireside chat at the UBS Genomics 2.0 and
Medtech Innovations Summit on August 11th at 2:00 p.m. P.T. in
Laguna Beach, California.
The fireside chat will be webcast live and can be accessed by
visiting the “Investor Calendar” page of the investor relations
section of the company's website here. A replay of the fireside
chat will be archived for a period of 30 days following the
conclusion of the live event.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic
biology and genomics company that has developed a disruptive DNA
synthesis platform to industrialize the engineering of biology. The
core of the platform is a proprietary technology that pioneers a
new method of manufacturing synthetic DNA by “writing” DNA on a
silicon chip. Twist is leveraging its unique technology to
manufacture a broad range of synthetic DNA-based products,
including synthetic genes, tools for next-generation sequencing
(NGS) preparation, and antibody libraries for drug discovery and
development. Twist is also pursuing longer-term opportunities in
digital data storage in DNA and biologics drug discovery. Twist
makes products for use across many industries including healthcare,
industrial chemicals, agriculture and academic research.
Follow us on Twitter | Facebook | LinkedIn | YouTube
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210810005222/en/
Angela Bitting SVP, Corporate Affairs 925- 202-6211
abitting@twistbioscience.com
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Jun 2024 to Jul 2024
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Jul 2023 to Jul 2024